Related Experiment Video

Updated: Dec 10, 2025

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

394

Phenotypes of Bronchopulmonary Dysplasia

Shih-Hsin Wang1, Po-Nien Tsao2,3

  • 1Department of Pediatrics, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.

International Journal of Molecular Sciences
|August 29, 2020
PubMed

Insights

Bronchopulmonary dysplasia (BPD) in preterm infants is a complex lung disease. New research explores metabolomics and pharmacometabolomics for personalized BPD treatment and improved infant respiratory outcomes.

Area of Science:

  • Neonatology
  • Pulmonology
  • Molecular Biology

Background:

  • Bronchopulmonary dysplasia (BPD) is a common chronic lung disease in preterm infants, posing a significant therapeutic challenge.
  • Inflammation is a key factor in BPD pathogenesis, leading to airway and vascular complications.
  • Current treatments like postnatal corticosteroids have variable efficacy and associated risks.

Purpose of the Study:

  • To explore novel therapeutic targets for BPD by understanding molecular mechanisms of lung development under inflammatory stress.
  • To investigate the potential of metabolomics and pharmacometabolomics for early BPD diagnosis, prognosis, and personalized treatment strategies.

Main Methods:

  • Review of emerging studies on molecular mechanisms of lung alveolarization.
  • Analysis of advances in metabolomics and pharmacometabolomics for biomarker discovery.
  • Discussion of future clinical, genetic, and translational research needs.

Main Results:

  • Inflammation significantly disrupts lung development in BPD.
  • Metabolomics offers opportunities for identifying BPD biomarkers.
  • Pharmacometabolomics can reveal metabolic signatures for tailored treatments.

Conclusions:

  • Understanding molecular pathways and utilizing metabolomic approaches are crucial for advancing BPD care.
  • Personalized medicine, informed by biomarkers and metabolic signatures, holds promise for improving respiratory outcomes in preterm infants.
  • Further research is needed to refine BPD classification and achieve individualized treatment strategies.

Keywords:
bronchopulmonary dysplasiacorticosteroidshyperoxiainflammationmetabolomicsphenotypepreterm

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

51.5K
Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

5.9K

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.0K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
63.6K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.3K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.3K